The precise in vivo and particularly cell‐specific and tissue‐specific effects of ADAM10 in diabetes still largely need to be determined, and our study is not powered to evaluate the role of ADAM10 as a marker of diabetic vascular complications. The gene discussed is ADAM10; the disease is diabetes mellitus.